[ad_1]
In order to guide consumers, SERNAC conducted a study to find out the price differences between the original drugs, the bioequivalents – whose studies demonstrate efficacy and safety similar to those of the original drugs -; and generics – which contain the same active ingredient as the original medicine.
The badysis included direct selling prices to consumers of products sold by Salcobrand, Ahumada and Cruz Verde pharmacies in the eastern part of the metropolitan area. [19659002] SERNAC national director, Lucas Del Villar, explained that the differences detected in this new SERNAC study are very relevant, considering that they are drugs that are in great demand by citizens because they are used to treat chronic diseases , such as hypertension. arterial, diabetes or cholesterol.
He also recalled that the consumer program announced by the Government envisaged measures to promote competition in the pharmaceutical industry and to facilitate the access of medicines to the population.
the agenda envisions a "digital pharmacy", which establishes that doctors can download recipes on this measure, reducing barriers to entry, will allow traceability of recipes and prevent their forgery, as well as the use of electronic devices in a central repository, making them available to providers authorized by the patient.
will encourage healthy competition.
In addition, this same agenda establishes a regulation requiring companies to report on web prices and the features of the products they offer so that users can easily cite, including drugs.
and Bioequivalents
For the treatment of a number of diseases, there are trilogies of drugs which include the drug of origin or of reference, branded bioequivalent and generic bioequivalent.
Bioequivalence makes it possible to demonstrate that two drugs containing the same drug or the same active ingredient, at the same dose, are similar in terms of quality, efficacy and safety for the recipient patient.
With the available information, the study succeeded in bringing the total to 28 comparisons or trios of products.
The largest percentage difference (3.162%) between an original drug or a reference drug e and a generic bioequivalent was detected in the omeprazole product (for gastric problems), where a consumer could pay $ 1,290 for the generic bioequivalent to 20 mg of omeprazole, 30 tablets; up to $ 42,090 in the case of the original Losec brand. In other words, a consumer can buy up to 32 boxes of generic bioequivalent medicine at the price of an original medicine.
Largest differences in trilogies:
In the case of trilogies, the greatest monetary difference is the drug for the treatment of cholesterol, with the active substance Atorvastatin. The initial remedy, Lipitor brand, Pfizer laboratory, 20 mg, 30 coated tablets, was found at at a maximum price of $ 57,590 ; while the generic bioequivalent Atorvastatin, Laboratorio Chile, had a minimum price of $ 2,890 . That is, a difference of $ 54,700, or in other words, a consumer could buy 19 boxes of generic bioequivalent.
For its part, the Lowe Bioequivalent of 20 mg, 30 coated tablets, of Laboratorio Saval-Eurolab, was found at a maximum value of 26 990 $ . Thus, a consumer could buy 9 boxes of generic bioequivalent for one of the bioequivalent brands.
A significant difference was also detected in the drug used for the treatment of depression, the active ingredient of which is Sertraline.
In this case, the original drug called Altruline of 50 mg, 30 coated tablets at the Roerig Laboratory was at a maximum price of $ 42,190 . ]; whereas the generic serqualin bioequivalent, Mintlab Laboratory, 50 mg, 30 coated tablets was detected at a minimum value of of $ 2,790 . That is to say a difference of 39 400 dollars or the equivalent of 15 boxes .
The generic mark called Sertac, 50 mg, 30 coated tablets, Andrómaco Laboratory, was found at its maximum value was $ 21,190 . In other words, a consumer could save $ 18,400 or, in other words, acquire 7 boxes of the generic Sertralina bioequivalent.
Higher Price Differences Between Channels
Consider Only Price medications indicated by the three chains could form a basket of 264 drugs badociated with 98 active ingredients.
In the case of the original drug basket, the most convenient chain has turned out to be Salcobrand; and in the case of bioequivalents (generic and brand), the most convenient chain has proven to be Cruz Verde.
The three drugs with greater differences between the chains were found to be copies of the bioequivalent brands Depurol Retard (Venlafaxine) 150 mg and 30 capsules; followed by Glicenex SR, 750 mg and 30 prolonged-release tablets; and the Sibilla contraceptive, in the presentation of 21 coated tablets.
Conclusions
- It is interesting to note that when purchasing the bioequivalent product, significant savings can be achieved by obtaining similar results in terms of efficiency and safety.
- ] For the treatment of several diseases, there are trilogies of drugs, including the original drug the bioequivalent brand and the generic bioequivalent.
- The largest percentage price difference has been detected in this case. of the drug Omeprazole (gastric problems), where a consumer may pay $ 1,290 for generic Omeprazole bioequivalent to $ 42,090 for the original Losec brand. That is to say that, for the price of an original medicine, a person could acquire up to 32 boxes of generic bioequivalent drug.
- In the case of trilogies, the greatest monetary difference was in . the drug for the treatment of cholesterol (atorvastatin). The original Lipitor was found at a maximum of $ 57,590; the Lowe brand is bioequivalent at $ 26,990; and the generic bioequivalent at $ 2,890.
- Pharmacies are required to report prices and available alternatives.
- To view this study in detail, visit www.sernac.cl
- . Consumers can quote the price of the drugs on the Web at www.cuantovale.gob.cl
If you plan to use the content of our agenda (text or simply the 39; information) under some means of communication, blogs or social networks, indicates the source, otherwise you incur an offense punishable by the law n ° 17.336 on the intellectual property. The foregoing does not apply to photographs and videos, as it is completely PROHIBITED to reproduce it for information purposes.
[ad_2]
Source link
